Global Ganja Report

A mother from California's Butte County appeared in court for a preliminary hearing June 11 to determine whether she should stand trial for breastfeeding her children while being a user of medical cannabis. Advocates have rallied around the case of Daisy Bram, 30, contending that she faces excessive prosecution on charges of felony child abuse and misdemeanor child endangerment stemming from a raid by county authorities on her home garden.  

Patient advocacy group Americans for Safe Access (ASA) has discovered that a second patient at Cedars-Sinai Medical Center has been denied a transplant in the past year because of medical marijuana use. In response, ASA sent a letter June 11 to the Cedars-Sinai Transplant Center on behalf of Toni Trujillo, a qualified medical marijuana patient who was removed from the kidney transplant list earlier this year. Trujillo has had kidney problems for most of her life and has been on dialysis for the past five years, since an existing kidney transplant began failing. The letter urges the world-renowned hospital to promptly re-list Trujillo and change its policy on medical marijuana.

Steve Ben Israel, legendary thespian, veteran of the ground-breaking Living Theatre troupe, and pioneer of what he called "performance life" (as opposed to performance art), died June 4 of lung cancer at his home in New York's Greenwich Village. He was 74.

New York's Gov. Andrew Cuomo held an Albany press conference June 4 to announce that he will ask state lawmakers to make possession of cannabis "in public view" a violation—essentially, the same as simple possession of under an ounce in the Empire State. Having the herb "in public view" is currently a misdemeanor, which is exploited by New York City police to rack up arrests in so-called "stop-and-frisks" by spooking citizens into displaying their stash—an illegal practice that has been the focus of a recent controversy. Cuomo's proposal immediately won the support of Mayor Michael Bloomberg, his top prosecutors and—amazingly—the New York Police Department.

In a 41-28 vote, the California State Assembly passed a bill May 31 to regulate the production and distribution of medical marijuana for qualified patients. Responding to calls from local officials, the State Supreme Court, and Attorney General Kamala Harris, the state legislature took a significant step toward clarifying the often-confusing terrain of medical marijuana distribution in California. AB 2312, the Medical Marijuana Regulate, Control and Tax Act, was introduced earlier this year by Assembly member Tom Ammiano (D-San Francisco) and others.

Patient advocates applauded Gov. Dannel Malloy June 1 for signing the country's 17th state medical marijuana law. "We are encouraged that state officials are standing up to federal intimidation and moving ahead with the passage of important public health laws," said Steph Sherer, director of Americans for Safe Access (ASA), which worked with local advocates to help pass the Connecticut law. "We hope other states follow Connecticut's lead in passing medical marijuana laws so that patients are not left unprotected and vulnerable to law enforcement actions."

Thanks to last year's redistricting, California now has a new Second Congressional District that some call the "Emerald Triangle District"—running from the Golden Gate to the Oregon border, through the cannabis counties of Mendocino, Humboldt and Trinity. The primary is in five days, and under California's new open-primary system, the two leading vote-getters will move on to the November general election, regardless of party. In the field of 12, the most outspoken herbal advocate is Garberville's veteran Earth First! tree-hugger Andy Caffrey.

Israeli scientists have developed a non-psychoative cannabis variety, in what is being portrayed as a boost for medical marijuana. According to Israel's Maariv newspaper, the new variety looks, smells and even tastes "the same" as psychoactive varieties. "It has the same scent, shape and taste as the original plant—it's all the same—but the numbing sensation that users are accustomed to has disappeared," said Tzahi Klein, head of development at Tikkun Olam, the firm that developed what an AFP account calls "the species." Klein adds: "Many of our patients who tried the new plant come back to us and say: 'You tricked me'"—because they assumed they had been given a placebo.